Sotera Health Co
$ 18.86
-0.26%
07 Aug - close price
- Market Cap 5,382,169,000 USD
- Current Price $ 18.86
- High / Low $ 19.79 / 18.70
- Stock P/E 33.09
- Book Value 2.18
- EPS 0.57
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.09 %
- ROE 0.28 %
- 52 Week High 19.85
- 52 Week Low 13.09
About
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and Asia. The company is headquartered in Broadview Heights, Ohio.
Analyst Target Price
$22.39
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-08 | 2025-05-01 | 2025-02-27 | 2024-11-05 | 2024-08-05 | 2024-05-02 | 2024-02-27 | 2023-11-01 |
| Reported EPS | 0.24 | 0.18 | 0.26 | 0.26 | 0.2 | 0.14 | 0.21 | 0.17 | 0.19 | 0.13 | 0.26 | 0.21 |
| Estimated EPS | 0.22 | 0.17 | 0.2422 | 0.22 | 0.17 | 0.12 | 0.2019 | 0.18 | 0.16 | 0.12 | 0.26 | 0.2 |
| Surprise | 0.02 | 0.01 | 0.0178 | 0.04 | 0.03 | 0.02 | 0.0081 | -0.01 | 0.03 | 0.01 | 0 | 0.01 |
| Surprise Percentage | 9.0909% | 5.8824% | 7.3493% | 18.1818% | 17.6471% | 16.6667% | 4.0119% | -5.5556% | 18.75% | 8.3333% | 0% | 5% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SHC
2026-08-06 20:11:10
Sotera Health Co (SHC) reported strong second-quarter 2026 results, with revenue reaching $321.38 million and diluted EPS of $0.19. The company saw significant year-over-year improvement across all key financial metrics, driven by higher service pricing and a favorable product mix. Despite ongoing expenses related to ethylene oxide remediation, management is confident in the company's ability to support growth through operational capacity expansion and strategic investments.
2026-08-06 14:10:14
Sotera Health (SHC) exceeded analyst expectations for its second-quarter earnings and revenue, reporting $0.26 adjusted EPS and $321.4 million in net revenues. The company also raised its full-year guidance for net revenues and adjusted EPS, and improved its net leverage to 3.0 times. Despite the strong results and positive outlook, SHC shares experienced a slight slip, potentially due to profit-taking or ongoing litigation costs related to its ethylene oxide sterilization facilities.
2026-08-06 14:10:14
Sotera Health (SHC) reported a significant profit rebound in Q2 2026, with net income rising to US$53.64 million and EPS to US$0.19, shifting from a net loss in the first half of the year. This turnaround in profitability is a key catalyst for its investment narrative, though the company still faces challenges including ethylene oxide litigation and the need for consistent execution to meet its reaffirmed 2026 revenue guidance of US$1.233 billion to US$1.251 billion.
2026-08-06 13:10:15
Sotera Health Company (SHC) reported strong Q2 2026 earnings, beating analyst estimates for both EPS ($0.26 vs. $0.24) and revenue ($321.38 million vs. $310.27 million). This marks the fourth consecutive quarter the company has surpassed both earnings and revenue expectations. Despite this positive performance, SHC shares have underperformed the S&P 500 year-to-date, and the stock currently holds a Zacks Rank #3 (Hold).
2026-08-06 13:10:14
Sotera Health (NASDAQ:SHC) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS expectations with sales up 9.2% year-on-year to $321.4 million. The company slightly increased its full-year revenue and Adjusted EPS guidance, demonstrating focused execution across its business units. Despite a mediocre 6.7% compounded annual growth rate over the last five years, recent performance shows an increase in demand, with organic revenue growing 8% year-on-year in Q2.
2026-08-06 12:10:15
Sotera Health Company (SHC) announced its Q2 revenue of $321.4 million, surpassing FactSet's estimate of $309.7 million. The company also reported Q2 adjusted EPS of $0.26 per share, exceeding the FactSet estimate of $0.24 per share. Following these results, Sotera Health has lifted the lower end of its 2026 guidance.
